Literature DB >> 7036767

Quartan malaria following splenectomy 36 years after infection.

H Tsuchida, K Yamaguchi, S Yamamoto, I Ebisawa.   

Abstract

Quartan malaria developed following splenectomy 36 years after infection in a 63-year-old hypertensive man. The patient underwent nephrectomy because of left renal calculus, increasing proteinuria and hypertension. Splenectomy was done additionally because metastasis of renal tumor to the spleen was suspected at the operation. Attention is drawn to the long silent infection with Plasmodium malariae and to the importance of the spleen in malaria.

Entities:  

Mesh:

Year:  1982        PMID: 7036767     DOI: 10.4269/ajtmh.1982.31.163

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  4 in total

1.  Meningitis after splenectomy.

Authors:  C D Selby; P J Toghill
Journal:  J R Soc Med       Date:  1989-04       Impact factor: 5.344

2.  Rodent blood-stage Plasmodium survive in dendritic cells that infect naive mice.

Authors:  Michelle N Wykes; Jason G Kay; Anthony Manderson; Xue Q Liu; Darren L Brown; Derek J Richard; Jiraprapa Wipasa; Suhua H Jiang; Malcolm K Jones; Chris J Janse; Andrew P Waters; Susan K Pierce; Louis H Miller; Jennifer L Stow; Michael F Good
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-20       Impact factor: 11.205

Review 3.  Alternative transmission routes in the malaria elimination era: an overview of transfusion-transmitted malaria in the Americas.

Authors:  Regina M Alho; Kim Vinícius Amaral Machado; Fernando F A Val; Nelson A Fraiji; Marcia A A Alexandre; Gisely C Melo; Judith Recht; André M Siqueira; Wuelton M Monteiro; Marcus V G Lacerda
Journal:  Malar J       Date:  2017-02-15       Impact factor: 2.979

Review 4.  Malaria in Brazil, Colombia, Peru and Venezuela: current challenges in malaria control and elimination.

Authors:  Judith Recht; André M Siqueira; Wuelton M Monteiro; Sonia M Herrera; Sócrates Herrera; Marcus V G Lacerda
Journal:  Malar J       Date:  2017-07-04       Impact factor: 2.979

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.